Keyphrases
Warfarin
83%
During Pregnancy
53%
Warfarin Dose
49%
Deferiprone
39%
Vitamin K
37%
Risk Factors
35%
Pharmacokinetics
33%
International Normalized Ratio
33%
Pregnancy Outcome
31%
Pregnant Women
29%
CYP2C9
28%
Israel
27%
Infliximab
26%
Anticoagulation
26%
VKORC1
25%
Clinical Outcomes
23%
QT Prolongation
23%
Vitamin K1
23%
Pharmacogenetics
23%
Prospective Controlled Study
23%
Gestational Exposure
23%
Dose Requirement
22%
Confidence Interval
22%
Inflammatory Bowel Disease
20%
Clinical Characteristics
17%
Antibodies to Infliximab
17%
β-Thalassemia (β-thal)
17%
Thalassemia
17%
Individual Sensitivity
16%
Warfarin Pharmacogenetics
16%
Non-associated
16%
Clinically Significant
16%
Tertiary Care Hospital
16%
Multivariate Analysis
16%
Hospitalized Patients
15%
Pyroglutamic Acid
15%
Community Setting
15%
Type 2 Diabetic Patients
15%
Varicella Zoster Immune Globulin
15%
Rosiglitazone
15%
Multivitamins
15%
Excessive Anticoagulation
15%
Voriconazole
15%
Database Testing
15%
Drug Withdrawal
15%
Nurture
15%
Nephrotoxicity
15%
Ifosfamide
15%
Agranulocytosis
15%
Low-dose Methotrexate
15%
Pharmacology, Toxicology and Pharmaceutical Science
Warfarin
100%
Pharmacokinetics
40%
Deferiprone
39%
Vitamin K Group
34%
Prospective Study
33%
Cohort Study
27%
Congenital Malformation
25%
Infliximab
25%
Phytomenadione
23%
Pharmacogenetics
21%
Disease
20%
Inflammatory Bowel Disease
19%
Tumor Necrosis Factor
16%
Infection
15%
Pyroglutamic Acid
15%
Agranulocytosis
15%
Thalassemia
15%
Rosiglitazone
15%
Diabetic Nephropathy
15%
Multivitamin
15%
Methotrexate
15%
Voriconazole
15%
Herpes Zoster Immunoglobulin
15%
Electronic Prescribing
15%
Non Insulin Dependent Diabetes Mellitus
15%
Allergic Rhinitis
15%
Breast Cancer
15%
Metabolic Acidosis
15%
Pharmacotherapy
15%
Elimination
15%
CYP2C9
14%
Diabetes Mellitus
13%
Free Radical
13%
Antihistaminic Agent
12%
Anticoagulant Agent
12%
Prevalence
11%
Drug-Drug Interaction
11%
Iron Chelating Agent
11%
Retrospective Study
11%
Premature Labor
10%
Malignant Neoplasm
10%
Adalimumab
9%
Crohn's Disease
9%
Trough Level
9%
Pharmacodynamics
9%
Chemotherapy
9%
Prothrombin
9%
Ascorbic Acid
9%
Drug Utilization
9%
Thalassemia Major
9%
Medicine and Dentistry
Prospective Study
26%
Drug Therapy
20%
Congenital Malformation
16%
Ifosfamide
15%
Voriconazole
15%
Clinical Decision Support System
15%
Nephrotoxicity
15%
Tertiary Care
15%
Diabetic Nephropathy
15%
Thalassemia
15%
Allergic Rhinitis
15%
Breast Cancer
15%
Health Care Cost
14%
Disease
13%
Electronic Prescribing
13%
Diabetes Mellitus
13%
Free Radical
13%
Internal Medicine
11%
Fetal Alcohol Syndrome
11%
Malignant Neoplasm
11%
First Trimester Pregnancy
10%
Histamine Antagonist
10%
Zoledronic Acid
10%
T Cell
9%
Pediatrics
9%
Retrospective Study
9%
Microalbuminuria
8%
Propofol
7%
Single Drug Dose
7%
Caffeine Citrate
7%
Breast Tumor
7%
Anticoagulation
7%
Fentanyl
7%
QT Prolongation
7%
Motherisk
7%
Acidosis
7%
Metabolic Acidosis
7%
Psychoactive Drug
7%
Beta Thalassemia
7%
Hypomagnesemia
7%
Intelligence Quotient
7%
Systemic Scleroderma
7%
Anion Gap
7%
Phylloquinone
7%
Multivitamin
7%
Isopentenyl Diphosphate
7%
Esmolol
7%
Nerve Cell Differentiation
7%
Gonad Function
7%
Drug Prescription
7%